glp-1 food industry impact news today Trends: Lifestyle Changes, Dining Habits, and Mental Health Business professor suggests GLP-1 drugs

Glucagon-like-peptide-1 (GLP-1) agonists are a group of drugs approved for use in management of type-2 diabetes and obesity

Meta-analyses on gray and white matter changes in T2DM patients with cognitive impairment have concluded that T2DM impairs cognitive function by affecting specific brain structures (Potenza et al., 2021)

This Colorado Medicaid Formulary (2019), or preferred drug list, is what your doctors and other providers should stick to when prescribing your medication

Several such studies are ongoing or planned, including those exploring weight management and metabolic support during therapy

In practical terms, the label says we do not know

GLP-1 (Glucagon-like Peptide-1) receptor agonists, such as Semaglutide GLP-1 and Liraglutide (Victoza), are increasingly becoming an integral part of our treatment strategies